22nd Century Group, Inc. (XXII): Nasdaq/NYSE listing notice — 22nd Century Group receives Nasdaq deficiency notice for bid price below $1.00

22nd Century Group, Inc.

Received Nasdaq letter on March 31, 2023 for non-compliance with Minimum Bid Price Requirement ($1.00).
Company has 180 days, until September 27, 2023, to regain compliance by closing at $1.00+ for 10 consecutive business days.
If not cured, may qualify for a second 180-day period if it meets other initial listing standards.
Company intends to monitor bid price and consider available options to regain compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

22nd Century Group, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

March 31, 2023, 22nd Century Group, Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department indicating that for the last 30 consecutive business days the Company's common stock did not maintain a minimum closing bid price of $1.00 (“Minimum Bid Price Requirement”) per share for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The notification of noncompliance has no immediate effect on the listing or trading of the Company's common stock on the Nasdaq Capital Market. Under Nasdaq Listing Rule 5810(c)(3)(A)

View on SEC.gov

18 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

22nd Century Group, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-040230

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.